These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6772525)

  • 21. Tumor associated antigen in ovarian carcinoma.
    Negishi Y; Mutai Y; Akiya K; Fujiwara Y; Singh G
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):126-32. PubMed ID: 6199439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT; Miya T; Knight JA; Knight DP
    Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasma.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1978 Aug; 131(7):780-7. PubMed ID: 686071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
    Flynn MK; Johnston W; Bigner S
    Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of OM-B monoclonal antibody-defined antigen associated with mucinous type human ovarian tumor.
    Nishida K; Ueda R; Sakakibara K; Minoura Y; Ohta M; Ariyoshi Y; Takahashi T
    Jpn J Cancer Res; 1993 Jan; 84(1):65-74. PubMed ID: 8449829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy.
    Pansini F; Bellinazzi A; Rainaldi V; Santoiemma M; Lenzi B; Jacobs M; Mollica G; Bagni B
    Gynecol Obstet Invest; 1986; 21(1):47-51. PubMed ID: 3005141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor markers in ovarian cancer: tumor-associated antigens.
    Barlow JJ; Bhattacharya M
    Semin Oncol; 1975 Sep; 2(3):203-9. PubMed ID: 827023
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1977 Apr; 127(7):705-10. PubMed ID: 66873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
    Bhattacharya M; Barlow JJ; Chu TM; Piver MS
    Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of a pregnancy-associated protein.
    Nakai M; Majima T; Atsumi M; Arai M
    Eur J Obstet Gynecol Reprod Biol; 1985 Nov; 20(5):275-88. PubMed ID: 3000844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration and purification of a specific antigen in Morris hepatoma 5123.
    Kyriazis AP; Wissler RW
    Lab Invest; 1972 Feb; 26(2):178-83. PubMed ID: 4333964
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
    Macdonald F; Bird R; Stokes H; Russell B; Crocker J
    J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific, antigenic protein of Guerin epithelioma.
    Pałka JA; Rzeczycki W
    Neoplasma; 1981; 28(5):527-32. PubMed ID: 6796896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ovarian tumour specific mucin antigen--immunohistological and biochemical studies.
    Ma J; Handley CJ; de Boer WG
    Pathology; 1983 Oct; 15(4):385-91. PubMed ID: 6371680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunochemical identification of a new embryonal antigen in ovarian tumor tissue].
    Kalashnikov VV; Borisenko SA; Tatarinov IS
    Biull Eksp Biol Med; 1976 Jun; 81(6):725-6. PubMed ID: 953311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic heterogeneity in human ovarian cancer.
    Welch WR; Niloff JM; Anderson D; Battaile A; Emery S; Knapp RC; Bast RC
    Gynecol Oncol; 1990 Jul; 38(1):12-6. PubMed ID: 2162315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours.
    Boerman OC; Makkink WK; Thomas CM; Hanselaar AG; Yedema CA; Kenemans P; Poels LG
    Eur J Cancer; 1990 Feb; 26(2):117-27. PubMed ID: 2138906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers in epithelial carcinoma of the ovary].
    Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
    Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
    [No Abstract]   [Full Text] [Related]  

  • 40. Soluble proteins of human bronchogenic carcinomas.
    Granlund DJ; Ritts RE
    Mayo Clin Proc; 1976 Jan; 51(1):19-27. PubMed ID: 765635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.